Choice of Surgery May Affect Quality of Life for Young Breast Cancer Survivors
SAN ANTONIO: Younger breast cancer patients who underwent mastectomy reported lower breast satisfaction and poorer psychosocial and sexual well-being...
Search/Filter
Loading...
Black Women Have Worse Breast Cancer Outcomes Despite Receiving Similar Treatment as White Women
SAN ANTONIO – Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had significantly...
Liquid Biopsies in SOLAR-1 Trial Predict Benefit of Alpelisib in PIK3CA-Mutant Breast Cancer
“SAN ANTONIO – Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared...
Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH
SAN ANTONIO – Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease...
Circulating Tumor Cell Count Could Help Choose Treatment for Metastatic Breast Cancer Patients
SAN ANTONIO – Circulating tumor-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment...
Axillary Radiotherapy and Lymph Node Surgery Yielded Comparable 10-year Outcomes for Patients with Breast Cancer
“SAN ANTONIO – Patients with early-stage breast cancer who had cancer detected in a sentinel lymph node biopsy had...
Accelerated Partial Breast Irradiation, Although Close, was Not Equivalent to Whole Breast Irradiation To Control Ipsilateral Breast Tumor Recurrence
“SAN ANTONIO – Data from the NRG (NSABP B-39/RTOG 0413) trial indicated that ipsilateral breast tumor recurrence (IBTR) rates...
Delaying Adjuvant Chemotherapy Associated With Worse Outcomes for Patients With Triple-negative Breast Cancer
“SAN ANTONIO – Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days after...
Adjuvant Chemotherapy Might Not Add Benefit in Breast Cancer Patients who Have Excellent Response to Neoadjuvant Chemotherapy
“SAN ANTONIO – Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk and...
Phase III KATHERINE Clinical Trial Crossed Early Reporting Boundary and Met its Primary Endpoint
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...